Intermittent Claudication Clinical Trial
Official title:
Effet Des Gestes de Revascularisation à l'étage Proximal
Verified date | July 2015 |
Source | University Hospital, Angers |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Observational |
The whole study is divided in 4 parallel protocols. The first protocol estimates the
reliability of the technique through test-retest recordings. The second protocol aims to
prove that exercise Tcpo2 is efficient to estimate the benefit of proximal revascularisation
on proximal and distal ischemia in patients suffering stage two lower extremity arterial
disease. The third protocol aims at estimating with exercise tcpo2 the eventual apparison of
proximal ischemia after aorto-bi-femoral bypasses. The last protocol is a transversal study
of patients with aorto-bi-femoral bypasses aiming to analyse the presence of proximal and
distal symptoms and ischemia.
The hypothesis for protocol 2 is that TcpO2 at exercise is significantly improved after
surgery at the aortic and primary iliac artery. The hypothesis for protocols 3 and 4 relates
on the hypothesis that a significant number of patients benefiting aorto-bi-femoral bypass
suffer isolated proximal pain/ischemia after surgery.
Amendement to the project has been recently validated to study the neurologic and bone
complication of chronic vascular ischemia
Status | Completed |
Enrollment | 165 |
Est. completion date | July 2008 |
Est. primary completion date | July 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - protocol 1 - 3 stage 2 claudication - Protocols 2 & 3 : Indication for surgery - protocol 4 : Patent aorto bio femoral bypass for more than 4 months - Ability to perform a treadmill test Exclusion Criteria: - Stage 4 LEAD - Aortic aneurysm - Acute coronary syndrom - claudication of documented non vascular origin (for protocols 1-3 only) |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | Laboratoire d'explorations vasculaires | Angers |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers | Sanofi-Synthelabo, Société Française de Médecine Vasculaire |
France,
Jaquinandi V, Abraham P, Picquet J, Paisant-Thouveny F, Leftheriotis G, Saumet JL. Estimation of the functional role of arterial pathways to the buttock circulation during treadmill walking in patients with claudication. J Appl Physiol (1985). 2007 Mar;10 — View Citation
Jaquinandi V, Picquet J, Bouyé P, Saumet JL, Leftheriotis G, Abraham P. High prevalence of proximal claudication among patients with patent aortobifemoral bypasses. J Vasc Surg. 2007 Feb;45(2):312-8. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400395 -
Clinical Trial for GNX80 in Intermittent Claudication
|
Phase 4 | |
Active, not recruiting |
NCT02341716 -
Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication
|
N/A | |
Completed |
NCT02041169 -
Lower Extremity Peripheral Arterial Disease and Exercise Ischemia
|
N/A | |
Completed |
NCT00822172 -
Evaluation of Cilostazol in Combination With L-Carnitine
|
Phase 4 | |
Recruiting |
NCT00538408 -
Whole Body Magnetic Resonance Angiography in Ischemic Patients
|
N/A | |
Completed |
NCT00388128 -
Caffeine and Intermittent Claudication
|
Phase 3 | |
Completed |
NCT00618670 -
Home-based vs. Supervised Exercise for People With Claudication
|
N/A | |
Recruiting |
NCT00146666 -
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
|
Phase 2 | |
Completed |
NCT00134277 -
Trial Comparing Different Medical Devices for Infragenual Dilatation
|
N/A | |
Completed |
NCT01256775 -
Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
|
Phase 2 | |
Completed |
NCT00029991 -
Extract of Ginkgo Biloba (EGB 761) and Vascular Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06299956 -
Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark
|
N/A | |
Not yet recruiting |
NCT05335161 -
A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease
|
Phase 1 | |
Completed |
NCT04390282 -
Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication
|
N/A | |
Completed |
NCT03271710 -
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
|
N/A | |
Completed |
NCT02380794 -
Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
|
Phase 2 | |
Active, not recruiting |
NCT02276937 -
Randomized Phase IIb Trial of DVC1-0101
|
Phase 2 | |
Completed |
NCT02097082 -
Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System
|
N/A | |
Recruiting |
NCT00539266 -
Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia
|
Phase 2/Phase 3 | |
Completed |
NCT00071266 -
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
|
Phase 3 |